Community Health Systems (CYH)
(Delayed Data from NYSE)
$3.56 USD
-0.22 (-5.82%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $3.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.56 USD
-0.22 (-5.82%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $3.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Zacks News
Here's Why You Should Stay Away From HCA Healthcare Now
by Zacks.com
Depressed revenues and elevated expenses make HCA Healthcare (HCA) an unattractive bet.
Why Should You Hold onto Acadia Healthcare Stock?
by Sapna Bagaria
Despite the recent drag in Acadia Healthcare's (ACHC) business volumes, the same is expected to bounce back, given the defensive demand for its mental and behavioral health business.
Community Health (CYH) Q1 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Community Health's (CYH) Q1 results hurt by softer revenues due to decline in admissions.
Community Health Systems (CYH) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -200.00% and -4.77%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
All You Need to Know About Community Health Systems (CYH) Rating Upgrade to Buy
by Zacks Equity Research
Community Health Systems (CYH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MEDNAX Plunges More Than 54% YTD: Will the Stock Rebound?
by Zacks Equity Research
Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds high prospects to revive its fortunes by virtue of its solid fundamentals.
MEDNAX Provides Updates Related to Coronavirus Pandemic
by Zacks Equity Research
MEDNAX (MD) takes several steps to help fight the COVID-19 pandemic.
Community Health Repeals 2020 Outlook Amid Coronavirus Woes
by Zacks Equity Research
Community Health (CYH) withdraws its current-year guidance amid prevalent market volatility induced by the COVID-19 spread.
Has Community Health Systems (CYH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CYH) Outperforming Other Medical Stocks This Year?
Tenet Healthcare (THC) Gets Rating Actions From Moody's
by Zacks Equity Research
Tenet Healthcare (THC) gets specific rating actions from credit rating agency Moody's. The outlook of the ratings is stable.
HCA Healthcare Makes Cost-Control Efforts Amid Coronavirus Woes
by Zacks Equity Research
HCA Healthcare (HCA) trims headcount to contain costs as its revenues are under pressure.
Tenet Heathcare Scraps Q1 & 2020 Guidance Amid Coronavirus Chaos
by Zacks Equity Research
Tenet Heathcare (THC) nullifies its first-quarter and 2020 outlook due to the COVID-19 pandemic.
HCA Healthcare Plunges Above 39% Year to date: Here's Why
by Zacks Equity Research
HCA Healthcare (HCA) stock plunges due to halt in elective surgeries, exorbitant costs and an escalating leverage level.
Coronavirus-Hit Hospital Stocks Gain on Senate Stimulus Help
by Sapna Bagaria
The stimulus bill will offer the much-required financial relief to COVID-19-plagued hospitals and lead to their share price appreciation.
Community Health Systems (CYH) Down 54.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Has Community Health Systems (CYH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CYH) Outperforming Other Medical Stocks This Year?
Tenet Healthcare Down 60.6% YTD: Should You Buy the Dip?
by Zacks Equity Research
Tenet Healthcare (THC) stock down following recommendations to keep elective procedures on hold due to coronavirus outbreak.
Chips Are Down for Hospitals on Coronavirus-Led Business Woes
by Sapna Bagaria
Stocks of hospital companies display a persistent downtrend as they put elective procedures on a back burner to brace up for the fight against a potential spike in coronavirus cases.
Universal Health Continues to Bank on Segmental Benefits
by Zacks Equity Research
Universal Health (UHS) thrives on its strong Acute Care and Behavioral platform segments.
Is Community Health Systems (CYH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (CYH) Outperforming Other Medical Stocks This Year?
Can Community Health (CYH) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
Community Health (CYH) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Here's Why Momentum Investors Will Love Community Health Systems (CYH)
by Zacks Equity Research
Does Community Health Systems (CYH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Community Health (CYH) Hits 52-Week High on Solid Q4 Results
by Zacks Equity Research
Community Health (CYH) reaches a 52-week high in Friday's trading session, backed by its strong fourth-quarter earnings performance.
Company News for Feb 21, 2020
by Zacks Equity Research
Companies In The News Are: IOTS, CYH, SAM, VMI
Community Health (CYH) Q4 Earnings Beat Estimates, Soar Y/Y
by Zacks Equity Research
Community Health's (CYH) Q4 results benefit from lower operating costs and expenses, partially offset by soft revenues.